John has led Aerogen from start-up in 1997 through a US merger, subsequent NASDAQ IPO, acquisition and MBO in 2008. Today Aerogen is recognized as a pioneer in high performance nebulisation and a global leader in ICU ventilator / Hospital based aerosol drug delivery. Its award winning products are employed in over 75 countries throughout the world helping to provide life critical interventions from the emergency department through to the NICU. Aerogen’s proprietary technology permits proteins, peptides, suspensions and solutions to be nebulised paving the way for targeted drug delivery to the lung. Since 2008 the company has grown revenues 30%+ year on year and in recognition of its export success Aerogen was awarded the prestigious European Business Award Ruban d’Honneur in 2011 and again in 2016, where John was also named the European Entrepreneur of the Year.  Aerogen was named the Irish Exporter of the Year 2014. In 2013, 2015 & 2016 Aerogen received the highest award granted by the American Association of Respiratory Care, the Zenith Award, for ‘providing products and services that enable respiratory care physicians and therapists to achieve clinical excellence’. Also in 2013 Aerogen was voted Irish Med-Tech Company of the year. A Chartered Engineer, John is recognized as a technology innovator and is credited with over a dozen commercialized International patents in products ranging from robotics to life-support ventilation. He holds an MBA from Oxford Brookes University and as an Adjunct Lecturer at National University of Ireland Galway (NUIG), he guest lectures on his core business interests of Innovation Strategies and Technology Entrepreneurship.  

A Serial Entrepreneur in a technology and innovation focused career spanning over 30 years, John has held executive level positions in R&D, Operations, Sales and General Management in both the SME and MNC environment.